awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38237495-518FDDE4-761D-42B2-ACC4-B173A21E449C
Q38237495-518FDDE4-761D-42B2-ACC4-B173A21E449C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38237495-518FDDE4-761D-42B2-ACC4-B173A21E449C
Recognizing and managing left ventricular dysfunction associated with therapeutic inhibition of the vascular endothelial growth factor signaling pathway.
P2860
Q38237495-518FDDE4-761D-42B2-ACC4-B173A21E449C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38237495-518FDDE4-761D-42B2-ACC4-B173A21E449C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d2ebb4e01e3e689e085cc7f499a093d1ead4d14a
P2860
Aflibercept and Docetaxel versus Docetaxel alone after platinum failure in patients with advanced or metastatic non-small-cell lung cancer: a randomized, controlled phase III trial.